{"organizations": [], "uuid": "c3d49b3602d23f4618c3139fa276995216ee1626", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.benzinga.com", "main_image": "", "site_section": "http://feeds.benzinga.com/benzinga/news/financing", "section_title": "Financing", "url": "http://www.benzinga.com/news/15/10/5879233/ipsen-announces-release-of-additional-batch-of-increlex-in-the-u-s", "country": "US", "title": "Ipsen Announces Release of Additional Batch of Increlex in the U.S.", "performance_score": 0, "site": "benzinga.com", "participants_count": 1, "title_full": "Ipsen Announces Release of Additional Batch of Increlex in the U.S.", "spam_score": 0.0, "site_type": "news", "published": "2015-10-01T11:31:00.000+03:00", "replies_count": 0, "uuid": "c3d49b3602d23f4618c3139fa276995216ee1626"}, "author": "Charles Gross", "url": "http://www.benzinga.com/news/15/10/5879233/ipsen-announces-release-of-additional-batch-of-increlex-in-the-u-s", "ord_in_thread": 0, "title": "Ipsen Announces Release of Additional Batch of Increlex in the U.S.", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Charles Gross , Benzinga Staff Writer {{following ? \"Following\" : \"Follow\"}} October 01, 2015 4:31am Comments Share: \nIpsen (OTC: IPSEY ) today announced that, in collaboration with the U.S. FDA (Food and Drug Administration), an additional batch of Increlex® will be available for commercial distribution starting in November, 2015. \nThe active substance in Increlex® is a recombinant insulin-like growth factor of human origin (IGF-1). IGF-1 is the direct hormonal mediator of stature and bone growth and must be present for normal growth of bones and cartilage in children. In severe primary IGF-1 deficiency, children's serum IGF-1 levels are low despite the presence of normal or elevated GH levels. If the IGF-1 is not present", "external_links": [], "published": "2015-10-01T11:31:00.000+03:00", "crawled": "2015-10-02T01:07:39.228+03:00", "highlightTitle": ""}